Yifeng Accounts Payable vs Deferred Long Term Liab Analysis

603939 Stock

23.42 0.12 0.52%

Yifeng Pharmacy financial indicator trend analysis is more than just analyzing Yifeng Pharmacy current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Yifeng Pharmacy is a good investment. Please check the relationship between Yifeng Pharmacy Accounts Payable and its Deferred Long Term Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Yifeng Pharmacy. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Accounts Payable vs Deferred Long Term Liab

Accounts Payable vs Deferred Long Term Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Yifeng Pharmacy Accounts Payable account and Deferred Long Term Liab. At this time, the significance of the direction appears to have totally related.

The correlation between Yifeng Pharmacy's Accounts Payable and Deferred Long Term Liab is 0.99. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Deferred Long Term Liab in the same time period over historical financial statements of Yifeng Pharmacy, assuming nothing else is changed. The correlation between historical values of Yifeng Pharmacy's Accounts Payable and Deferred Long Term Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Yifeng Pharmacy are associated (or correlated) with its Deferred Long Term Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Deferred Long Term Liab has no effect on the direction of Accounts Payable i.e., Yifeng Pharmacy's Accounts Payable and Deferred Long Term Liab go up and down completely randomly.

Correlation Coefficient

0.99

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Accounts Payable

An accounting item on the balance sheet that represents Yifeng Pharmacy obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Yifeng Pharmacy are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.

Most indicators from Yifeng Pharmacy's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Yifeng Pharmacy current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Yifeng Pharmacy. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Selling General Administrative is expected to grow to about 5.9 B, whereas Tax Provision is forecasted to decline to about 286.7 M.

	2021	2022	2023	2024 (projected)
Operating Income	1.5B	2.0B	2.1B	2.2B
Total Revenue	15.3B	19.9B	22.6B	23.7B

Operating Income Total Revenue

Yifeng Pharmacy fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Accounts Payable	Cash	Other Assets	Net Receivables	Inventory	Other Current Assets	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Retained Earnings	Good Will	Net Tangible Assets	Short Term Investments	Deferred Long Term Liab	Long Term Investments	Total Current Assets	Non Current Assets Total	Non Currrent Assets Other	Non Current Liabilities Total	Common Stock Shares Outstanding
Total Assets		0.42	1.0	0.99	0.33	0.99	0.96	1.0	0.98	1.0	0.66	1.0	0.86	0.98	0.97	0.99	0.89	0.8	0.48	1.0	0.57	0.93	0.92	0.31	0.9	0.71
Other Current Liab	0.42		0.38	0.43	0.19	0.36	0.57	0.44	0.35	0.47	0.61	0.41	0.66	0.43	0.41	0.34	0.63	0.42	-0.4	0.41	0.41	0.55	0.54	0.19	0.63	-0.14
Total Current Liabilities	1.0	0.38		0.98	0.33	1.0	0.96	0.99	0.98	0.99	0.62	1.0	0.84	0.96	0.97	1.0	0.86	0.78	0.48	0.99	0.53	0.92	0.92	0.27	0.89	0.73
Total Stockholder Equity	0.99	0.43	0.98		0.32	0.98	0.95	0.99	0.98	0.99	0.72	0.98	0.87	0.99	0.94	0.98	0.89	0.81	0.51	0.99	0.62	0.92	0.91	0.35	0.89	0.68
Other Liab	0.33	0.19	0.33	0.32		0.33	0.33	0.31	0.33	0.34	0.23	0.34	0.41	0.27	0.31	0.33	0.38	0.38	0.13	0.35	0.23	0.42	0.41	0.09	0.36	0.36
Accounts Payable	0.99	0.36	1.0	0.98	0.33		0.95	0.99	0.99	0.99	0.63	1.0	0.83	0.96	0.96	1.0	0.86	0.78	0.5	0.99	0.53	0.91	0.91	0.26	0.87	0.74
Cash	0.96	0.57	0.96	0.95	0.33	0.95		0.97	0.92	0.97	0.68	0.96	0.89	0.94	0.96	0.94	0.91	0.75	0.34	0.96	0.57	0.94	0.91	0.38	0.95	0.59
Other Assets	1.0	0.44	0.99	0.99	0.31	0.99	0.97		0.97	0.99	0.67	0.99	0.86	0.98	0.97	0.99	0.88	0.81	0.47	1.0	0.61	0.93	0.92	0.37	0.91	0.69
Net Receivables	0.98	0.35	0.98	0.98	0.33	0.99	0.92	0.97		0.98	0.68	0.98	0.82	0.95	0.92	0.99	0.85	0.77	0.5	0.98	0.57	0.9	0.89	0.25	0.83	0.73
Inventory	1.0	0.47	0.99	0.99	0.34	0.99	0.97	0.99	0.98		0.69	0.99	0.88	0.97	0.96	0.99	0.91	0.79	0.42	0.99	0.57	0.93	0.94	0.29	0.92	0.67
Other Current Assets	0.66	0.61	0.62	0.72	0.23	0.63	0.68	0.67	0.68	0.69		0.62	0.83	0.67	0.51	0.62	0.84	0.5	0.11	0.65	0.84	0.71	0.66	0.5	0.65	0.33
Total Liab	1.0	0.41	1.0	0.98	0.34	1.0	0.96	0.99	0.98	0.99	0.62		0.85	0.96	0.98	1.0	0.87	0.79	0.46	1.0	0.52	0.92	0.93	0.27	0.9	0.72
Intangible Assets	0.86	0.66	0.84	0.87	0.41	0.83	0.89	0.86	0.82	0.88	0.83	0.85		0.83	0.81	0.82	0.97	0.78	0.2	0.85	0.65	0.96	0.93	0.36	0.93	0.58
Common Stock	0.98	0.43	0.96	0.99	0.27	0.96	0.94	0.98	0.95	0.97	0.67	0.96	0.83		0.94	0.96	0.86	0.82	0.52	0.97	0.61	0.9	0.89	0.37	0.88	0.66
Property Plant Equipment	0.97	0.41	0.97	0.94	0.31	0.96	0.96	0.97	0.92	0.96	0.51	0.98	0.81	0.94		0.96	0.82	0.81	0.44	0.97	0.46	0.91	0.91	0.28	0.92	0.68
Retained Earnings	0.99	0.34	1.0	0.98	0.33	1.0	0.94	0.99	0.99	0.99	0.62	1.0	0.82	0.96	0.96		0.84	0.8	0.52	0.99	0.53	0.91	0.91	0.26	0.87	0.75
Good Will	0.89	0.63	0.86	0.89	0.38	0.86	0.91	0.88	0.85	0.91	0.84	0.87	0.97	0.86	0.82	0.84		0.73	0.21	0.87	0.64	0.95	0.93	0.39	0.94	0.6
Net Tangible Assets	0.8	0.42	0.78	0.81	0.38	0.78	0.75	0.81	0.77	0.79	0.5	0.79	0.78	0.82	0.81	0.8	0.73		0.44	0.81	0.53	0.87	0.88	0.22	0.78	0.7
Short Term Investments	0.48	-0.4	0.48	0.51	0.13	0.5	0.34	0.47	0.5	0.42	0.11	0.46	0.2	0.52	0.44	0.52	0.21	0.44		0.47	0.27	0.36	0.25	0.33	0.21	0.62
Deferred Long Term Liab	1.0	0.41	0.99	0.99	0.35	0.99	0.96	1.0	0.98	0.99	0.65	1.0	0.85	0.97	0.97	0.99	0.87	0.81	0.47		0.57	0.92	0.93	0.3	0.9	0.71
Long Term Investments	0.57	0.41	0.53	0.62	0.23	0.53	0.57	0.61	0.57	0.57	0.84	0.52	0.65	0.61	0.46	0.53	0.64	0.53	0.27	0.57		0.6	0.52	0.77	0.53	0.33
Total Current Assets	0.93	0.55	0.92	0.92	0.42	0.91	0.94	0.93	0.9	0.93	0.71	0.92	0.96	0.9	0.91	0.91	0.95	0.87	0.36	0.92	0.6		0.97	0.35	0.95	0.72
Non Current Assets Total	0.92	0.54	0.92	0.91	0.41	0.91	0.91	0.92	0.89	0.94	0.66	0.93	0.93	0.89	0.91	0.91	0.93	0.88	0.25	0.93	0.52	0.97		0.22	0.95	0.73
Non Currrent Assets Other	0.31	0.19	0.27	0.35	0.09	0.26	0.38	0.37	0.25	0.29	0.5	0.27	0.36	0.37	0.28	0.26	0.39	0.22	0.33	0.3	0.77	0.35	0.22		0.38	0.18
Non Current Liabilities Total	0.9	0.63	0.89	0.89	0.36	0.87	0.95	0.91	0.83	0.92	0.65	0.9	0.93	0.88	0.92	0.87	0.94	0.78	0.21	0.9	0.53	0.95	0.95	0.38		0.6
Common Stock Shares Outstanding	0.71	-0.14	0.73	0.68	0.36	0.74	0.59	0.69	0.73	0.67	0.33	0.72	0.58	0.66	0.68	0.75	0.6	0.7	0.62	0.71	0.33	0.72	0.73	0.18	0.6

Click cells to compare fundamentals

Yifeng Pharmacy Account Relationship Matchups

Yifeng Pharmacy fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	9.2B	12.9B	17.1B	21.0B	24.1B	25.3B
Other Current Liab	321.2M	525.1M	672.4M	1.0B	22.6M	21.5M
Total Current Liabilities	3.7B	5.9B	6.7B	9.7B	11.3B	11.8B
Total Stockholder Equity	4.5B	5.5B	7.5B	8.6B	9.8B	10.3B
Other Liab	54.1M	53.9M	52.5M	78.4M	90.2M	48.4M
Accounts Payable	3.0B	3.8B	4.8B	6.8B	8.2B	8.6B
Cash	1.4B	3.4B	2.9B	4.1B	3.6B	3.7B
Other Assets	239.8M	400.0M	517.8M	568.5M	653.7M	686.4M
Net Receivables	953.0M	830.3M	1.1B	1.8B	2.1B	2.2B
Inventory	1.8B	2.2B	3.0B	3.6B	3.8B	4.0B
Other Current Assets	547.5M	341.7M	356.7M	466.0M	384.1M	298.8M
Total Liab	4.5B	7.2B	9.2B	11.9B	13.7B	14.4B
Intangible Assets	355.1M	375.3M	396.5M	485.5M	474.5M	271.2M
Common Stock	378.9M	531.5M	718.8M	721.7M	830.0M	871.5M
Property Plant Equipment	528.0M	3.6B	4.5B	4.9B	5.6B	5.9B
Retained Earnings	1.5B	2.1B	2.8B	3.9B	4.8B	5.0B
Good Will	3.0B	3.3B	3.7B	4.2B	4.6B	2.6B
Net Tangible Assets	1.1B	1.7B	3.4B	3.9B	4.5B	2.3B
Short Term Investments	193.2M	744.8M	152.2M	50.0M	1.6B	1.7B
Deferred Long Term Liab	207.0M	267.4M	379.6M	430.7M	495.3M	520.1M
Total Current Assets	5.0B	7.7B	7.9B	10.6B	12.1B	6.8B
Non Current Assets Total	4.2B	4.9B	9.1B	10.5B	12.0B	6.4B
Non Currrent Assets Other	12.2M	58.4M	28.4M	7.2M	30.3M	23.9M
Non Current Liabilities Total	741.3M	2.0B	2.4B	2.3B	2.4B	1.5B
Common Stock Shares Outstanding	689.6M	691.0M	718.8M	721.7M	1.2B	845.4M
Net Invested Capital	5.2B	7.8B	7.8B	8.8B	9.9B	7.5B
Net Working Capital	1.3B	2.9B	1.2B	918.9M	859.4M	1.2B
Long Term Debt	687.2M	2.0B	365.6M	228.7M	133.6M	126.9M
Capital Stock	378.9M	531.5M	718.8M	721.7M	1.0B	685.4M

Currently Active Assets on Macroaxis

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C
MSFT	Microsoft
GM	General Motors

Other Information on Investing in Yifeng Stock

Balance Sheet is a snapshot of the financial position of Yifeng Pharmacy at a specified time, usually calculated after every quarter, six months, or one year. Yifeng Pharmacy Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Yifeng Pharmacy and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Yifeng currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Yifeng Accounts Payable vs Deferred Long Term Liab Analysis

Accounts Payable vs Deferred Long Term Liab

Accounts Payable vs Deferred Long Term Liab Correlation Analysis

Correlation Coefficient

Accounts Payable

Deferred Long Term Liab

Yifeng Pharmacy fundamental ratios Correlations

Yifeng Pharmacy Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Yifeng Pharmacy fundamental ratios Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Yifeng Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Liabilities	+ 1.0	Total Assets
Other Assets	+ 1.0	Total Assets
Inventory	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Assets
Deferred Long Term Liab	+ 1.0	Total Assets
Accounts Payable	+ 1.0	Total Current Liabilities

Short Term Investments	- 0.4	Other Current Liab
Common Stock Shares Outstanding	- 0.14	Other Current Liab